DAP-16153-74048
2 vaccinations
1 coded response
6 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 151 / PA
- Registered
- 2021-03-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-26
Dose 1 — Pfizer-BioNTech
-
2021-03-19
Dose 2 — Pfizer-BioNTech
-
2021-03-24
Registered in v-safe
- 2021-03-24
- 2021-03-26
- 2021-04-02
- 2021-04-18
- 2021-04-23
-
2021-04-30
Survey response — day 42, dose 2MedDRA: Nephrolithiasis — Feeling: Fair · Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: Kidney stonesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-30
Report sent to call center — day 42, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-05-21
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-26 | Pfizer-BioNTech | |
| 2 | 2021-03-19 | Pfizer-BioNTech |
Call center
1 call center case
1 successful
Free text
Release 8 — day 42, dose 2
Symptoms: Kidney stones
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nephrolithiasis | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release